BIOMARKER:

HER-2 A775_G776insYVMA

Entrez ID:

Related biomarkers:

‹

›

HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer NSCLC	rivoceranib + pyrotinib Sensitive: C3 – Early Trials
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer NSCLC	afatinib Sensitive: C3 – Early Trials
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer NSCLC	pyrotinib Sensitive: C3 – Early Trials
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer NSCLC	dacomitinib Sensitive: C3 – Early Trials
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Lung Adenocarcinoma LUAD	tarloxotinib bromide Sensitive: C4 – Case Studies
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Lung Adenocarcinoma LUAD	ado-trastuzumab emtansine Sensitive: C4 – Case Studies
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Lung Adenocarcinoma LUAD	afatinib Sensitive: C4 – Case Studies
HER-2 A775_G776insYVMA HER-2 A775_G776insYVMA	Lung Adenocarcinoma LUAD	pyrotinib Sensitive: D – Preclinical

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations